Adjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trialJulien Edeline, Éveline Boucher, J Phelip et al.|Annals of Oncology|2017Cited by 4